Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The sites will then by fully used by Novo Nordisk for filling its injection pens. Novo Holdings, Novo Nordisk and Catalent ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...